EGFR MUTATION
Clinical trials for EGFR MUTATION explained in plain language.
Never miss a new study
Get alerted when new EGFR MUTATION trials appear
Sign up with your email to follow new studies for EGFR MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill targets key drivers of advanced lung cancer in groundbreaking trial
Disease control OngoingThis early-stage study is testing a new oral medication called BAY 2927088 for people with advanced non-small cell lung cancer that has specific genetic changes (EGFR or HER2 mutations). The main goals are to find a safe and tolerable dose, understand how the drug moves through t…
Matched conditions: EGFR MUTATION
Phase: PHASE1, PHASE2 • Sponsor: Bayer • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC
-
Scientists hunt hidden causes of lung cancer drug resistance
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to understand why lung cancers with specific genetic changes eventually stop responding to targeted drug treatments. Researchers will analyze tumor and blood samples from 40 patients whose cancer progressed while on these drugs. They will use advanced genetic test…
Matched conditions: EGFR MUTATION
Sponsor: Chang Gung Memorial Hospital • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:42 UTC